Company Overview
Company Type: Private Company
Website: www.puzzlemed.com
Number of Employees: -
Year Founded: 2018
Total Amount Raised (CAD mm)†: 34.00
Total Rounds of Funding**:4
Latest Post-Money Valuation ($ mm) -
Latest Pre-Money Valuation ($ mm) -
† This number reflects the estimated value of the total new money raised through private placement rounds.
** This value is an estimate of the total number of funding rounds this company has received.


Business Description
Puzzle Medical Devices Inc. develops minimally invasive long-term hemodynamic transcatheter pumps to treat the disease of heart failure. The company was incorporated in 2018 and is based in Montreal, Canada.


Financial Information (Currency: CAD, in mm)
Total Revenue
-
Operating Income
-
Total Assets
-
Gross Profit
-
EBITDA
-
Total Debt
-
Net Income
-
Estimated Number of Employees
-
Net Debt
-
* Hover over data point numbers for date and source.

Key Professionals
Name
Title
Doucet-Martineau, Jade 
Co-Founder & CEO
Georges, Gabriel 
Co-Founder
Trudeau, François 
Co-Founder
Généreux, Philippe 
Chief Medical Officer

Key Board Members
Name
Title
Prim, David 
Director


Primary Industry Classification
Health Care Equipment


Primary Office Location
A-329, 1001 Lenoir Street | Montreal, QC | H4C 2Z6 | Canada
Phone: 514-742-2580   

Current and Pending Investors
Investor
Initial Investment Date
Stake Type
Current Stake Amount
Round(s)
Ajax Health III LLC
Feb-27-2023
Minority
-
Series A
BDC Capital Inc.
Feb-27-2023
Unknown
-
Series A
Desjardins Capital
Feb-27-2023
Unknown
-
Series A
Hellman & Friedman LLC
Feb-27-2023
Unknown
-
Series A
KKR & Co. Inc. (NYSE:KKR)
Feb-27-2023
Unknown
-
Series A


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Feb-27-2023
Feb-27-2023
Private Placement
Target
Puzzle Medical Devices Inc.
Longview Ventures,Desjardins Capital,BDC Capital Inc.,Ajax Health III LLC,Hellman & Friedman LLC,KKR & Co. Inc. (NYSE:KKR) Buyer Funds:Thrive Venture Fund and Lab for Women

25.03
Jan-24-2022
Jan-24-2022
Private Placement
Target
Puzzle Medical Devices Inc.
Broadview Ventures, Inc.,Aster-X Capital Management B.V.,Cathexis Capital LLC,Boreal Ventures,AQC Capital

-
Jun-15-2020
Jun-15-2020
Private Placement
Target
Puzzle Medical Devices Inc.


-
Dec-31-2019
Dec-31-2019
Private Placement
Target
Puzzle Medical Devices Inc.
Front Row Ventures

-
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Feb-27-2023
Private Placements
Puzzle Medical Devices Inc. announced that it has received CAD 34 million in funding from Desjardins Capital, Longview Ventures, BDC Capital Inc., Hellman & Friedman LLC, Ajax Health III LLC, KKR & Co. Inc.
Jan-24-2022
Private Placements
Puzzle Medical Devices Inc. announced that it has received funding from Broadview Ventures, Inc., Cathexis Capital LLC, Aster-X Capital Management BV, Boreal Ventures, AQC Capital
Jan-24-2022
Executive/Board Changes - Other
Puzzle Medical Devices Inc. Announces Board Appointments
Feb-08-2021
Product-Related Announcements
Puzzle Medical Devices Inc. Receives U.S. Food and Drug AdministrationBreakthrough Device Designation for Its Revolutionary Minimally Invasive Transcatheter Heart Pump
Oct-05-2020
Company Conference Presentations
Puzzle Medical Devices Inc. Presents at The MedTech Conference, Oct-05-2020


Last 10 Investment Research Documents
No Investment Research returned. This can be caused by entitlement settings or your template settings.


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.

Key Board Members Details
Name
Title
Phone
Fax
Email
Prim, David 
Director
514-742-2580
-

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Doucet-Martineau, Jade 
Co-Founder & CEO
1-514-742-2580
-
jade.doucet-martineau@puzzlemed.com
Georges, Gabriel 
Co-Founder
1-514-758-8971
-
gabriel.georges@puzzlemed.com
Trudeau, François 
Co-Founder
1-418-261-4799
-
francois.trudeau@puzzlemed.com
Généreux, Philippe 
Chief Medical Officer
514-742-2580
-
philippe.genereux@puzzlemed.com
* denotes that the relationship is proprietary

S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 
